The effect of digoxin on mortality and morbidity in patients with heart failure

New England Journal of Medicine

Volumn 336, Issue 8, 1997, Pages 525-533

  Garg, Rekha ^b   Gorlin, Richard ^a   Smith, Thomas ^b   Yusuf, Salim ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC GLYCOSIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGOXIN BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; ARRHYTHMIA; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; DIGOXIN; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; STROKE VOLUME; TREATMENT OUTCOME;

EID: 0031051347     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199702203360801     Document Type: Article

References (11)

1. Kelly RA, Smith TW. Digoxin in heart failure: implications of recent trials. J Am Coll Cardiol 1993;22:Suppl A:107A-112A.
2. Yusuf S, Wittes J, Bailey K, Furberg C. Digitalis - a new controversy regarding an old drug: the pitfalls of inappropriate methods. Circulation 1986;73:14-8.
3. Jaeschke R, Oxman AD, Guyatt GH. To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis. Am J Med 1990;88:279-86.
4. Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med 1993;329:1-7.
5. Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED Trial. J Am Coll Cardiol 1993;22:955-62.
6. Yusuf S, Garg R, Held P, Gorlin R. Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure. Am J Cardiol 1992;69:64G-70G.
7. The Digitalis Investigation Group. Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. Control Clin Trials 1996;17:77-97.
8. Jelliffe RW, Brooker GA. A nomogram for digoxin therapy. Am J Med 1974;57:63-8.
9. Yusuf S. Obtaining reliable information from randomized controlled trials in congestive heart failure and left ventricular dysfunction. In: Brachman W, Dietz R, Kubler W, eds. Heart failure and arrhythmias. Berlin, Germany: Springer-Verlag, 1990:147-60.
10. Yusuf S, Teo KK. Inotropic agents increase mortality in patients with congestive heart failure. Circulation 1990;82:Suppl III:III-673. abstract.
11. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991;325: 1468-75.